ATE216368T1 - Heterocyclische carboxyalkylderivate - Google Patents

Heterocyclische carboxyalkylderivate

Info

Publication number
ATE216368T1
ATE216368T1 AT95120208T AT95120208T ATE216368T1 AT E216368 T1 ATE216368 T1 AT E216368T1 AT 95120208 T AT95120208 T AT 95120208T AT 95120208 T AT95120208 T AT 95120208T AT E216368 T1 ATE216368 T1 AT E216368T1
Authority
AT
Austria
Prior art keywords
heterocyclic
carboxyalkyl derivatives
compounds
benzothiazolylmethyl
naphthylmethyl
Prior art date
Application number
AT95120208T
Other languages
English (en)
Inventor
Takayuki Kotani
Kaoru Okamoto
Yasuhiro Nagaki
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Application granted granted Critical
Publication of ATE216368T1 publication Critical patent/ATE216368T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT95120208T 1994-12-20 1995-12-20 Heterocyclische carboxyalkylderivate ATE216368T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33582194 1994-12-20

Publications (1)

Publication Number Publication Date
ATE216368T1 true ATE216368T1 (de) 2002-05-15

Family

ID=18292789

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95120208T ATE216368T1 (de) 1994-12-20 1995-12-20 Heterocyclische carboxyalkylderivate

Country Status (5)

Country Link
US (1) US5912261A (de)
EP (1) EP0718290B1 (de)
AT (1) ATE216368T1 (de)
DE (1) DE69526413T2 (de)
ES (1) ES2176277T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197806B1 (en) 1995-12-20 2001-03-06 Nippon Zoki Pharmaceutical Co., Ltd. Eliminating agent for activated oxygen and free radicals
JPH10182460A (ja) * 1996-12-27 1998-07-07 Nippon Zoki Pharmaceut Co Ltd 3−デオキシグルコソン生成阻害剤
AU754989B2 (en) 1998-11-16 2002-11-28 Nippon Zoki Pharmaceutical Co., Ltd. A therapeutic agent for intractable vasculitis
JP4711523B2 (ja) 2001-02-13 2011-06-29 日本臓器製薬株式会社 低アルブミン血症改善剤
US7115620B2 (en) 2001-10-30 2006-10-03 Wyeth 1,3-disubstituted-2-thioxo-imidazolidine-4,5-diones as potassium channel openers
US7135492B2 (en) 2001-10-30 2006-11-14 Wyeth 1,3-disubstituted-2- thioxo-imidazolidine-4,5-dione derivatives useful in the treatment of atherosclerosis
TW200845994A (en) * 2007-01-12 2008-12-01 Smithkline Beecham Corp N-substituted glycine derivatives: prolyl hydroxylase inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US32919A (en) * 1861-07-23 Cot or bedstead
US4099007A (en) * 1969-04-02 1978-07-04 Hoechst Aktiengesellschaft N,n-substituted 2,4,5-triketoimidazolidines and a process for their preparation
CH563711A5 (en) * 1972-03-03 1975-07-15 Ciba Geigy Ag Agents for regulating plant metabolism - contg. imidazolidine-2,4,5-trione-3-carboxylic acid derivs.
US3818031A (en) * 1971-03-26 1974-06-18 Ciba Geigy Corp Imidazolidinetrionecarboxylic acid derivatives
DE2612926A1 (de) * 1976-03-26 1977-10-06 Boehringer Mannheim Gmbh Neue acyl-derivate der 6-(alpha- amino-phenylacetamido)-penicillansaeure
AU578068B2 (en) * 1984-03-08 1988-10-13 Nippon Zoki Pharmaceutical Co., Ltd. Hydantoin derivatives and pharmaceutical compositions containing them
US4656034A (en) * 1985-05-20 1987-04-07 Survival Technology, Inc. Absorption enhancing agents
US4658830A (en) 1984-08-08 1987-04-21 Survival Technology, Inc. Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms
EP0192660B1 (de) * 1984-08-08 1992-11-19 Survival Technology, Inc. Absorptionsverbesserer
US4661469A (en) * 1984-08-08 1987-04-28 Survival Technology, Inc. t-PA composition capable of being absorbed into the blood stream and method of administration
EP0194226B1 (de) * 1985-02-06 1990-02-07 Nippon Zoki Pharmaceutical Co. Ltd. Ein Imidazolidintrion-Derivat oder ein seiner pharmazeutisch akzeptierbaren Salze enthaltende pharmazeutische Zusammenstellung
JP2567593B2 (ja) * 1986-12-29 1996-12-25 日本臓器製薬株式会社 イミダゾリジントリオン誘導体及び該化合物を有効成分として含有するアレルギ−性疾患治療剤
JPH01156965A (ja) * 1987-09-29 1989-06-20 Taiho Yakuhin Kogyo Kk チオヒダントイン化合物
US4904380A (en) * 1988-01-26 1990-02-27 Pall Corporation Precoat filter assembly
JP2544183B2 (ja) * 1988-07-29 1996-10-16 日本臓器製薬株式会社 新規パラバン酸誘導体及び該化合物を有効成分として含有する医薬組成物
JPH02225485A (ja) * 1989-02-27 1990-09-07 Taiho Yakuhin Kogyo Kk チエノピリミジン―3―酢酸誘導体
JP2678499B2 (ja) * 1989-08-09 1997-11-17 日本臓器製薬 株式会社 尿毒症毒素低下剤
US5691335A (en) * 1994-07-29 1997-11-25 Suntory Limited Imidazolidine derivative and use thereof

Also Published As

Publication number Publication date
DE69526413T2 (de) 2002-10-31
EP0718290B1 (de) 2002-04-17
US5912261A (en) 1999-06-15
EP0718290A1 (de) 1996-06-26
DE69526413D1 (de) 2002-05-23
ES2176277T3 (es) 2002-12-01

Similar Documents

Publication Publication Date Title
ID22447A (id) Senyawa gula, bahan pengegel, komposisi bahan pengegel, proses penyediaannya serta komposisi gel
EP1357115A4 (de) Alkansäurederivate, verfahren zu deren herstellung und deren verwendung
AU6208990A (en) N-substituted-4-pyrimidinamines and pyrimidindiamines, a process for their preparation and their use as medicaments
IL145759A0 (en) Amine derivatives and pharmaceutical compositions containing the same
DE69918695D1 (de) Sauerstoffhaltige heterocyclische verbindungen
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
KR900014388A (ko) 에세롤린의 카보네이트 유도체, 이의 제조방법 및 약제로서의 용도
DE69526413D1 (de) Heterocyclische Carboxyalkylderivate
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
HUT50337A (en) Process for producing benzoxazine derivatives and pharmaceutical compositions comprising the compounds
ATE275572T1 (de) Malto-oligosaccharid-derivate und ihre anwendungen
NZ228915A (en) Nitromethylsulphonyl- substituted heterocyclic compounds, medicaments, and intermediates
DE69529807D1 (de) Neue Parabansäure-Derivate als Aldose-Reduktase Inhibitoren
WO2001004122A3 (en) New 2,3-benzodiazepine derivatives
AU2002214266A1 (en) Carbamate derivatives, process for producing the same and use thereof
GR3004321T3 (de)
LU88449I2 (fr) Fleroxacine et ses dérivés pharmaceutiquement acceptables.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties